Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM Antoniou, A Pataka, D Bouros… - Pulmonary pharmacology …, 2007 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM Antoniou, A Pataka, D Bouros… - Pulmonary …, 2007 - hero.epa.gov
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM Antoniou, A Pataka, D Bouros… - Pulmonary …, 2007 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM Antoniou, A Pataka, D Bouros… - Pulmonary Pharmacology …, 2007 - infona.pl
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.
KM Antoniou, A Pataka, D Bouros… - Pulmonary …, 2006 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …
[引用][C] Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM ANTONIOU - Pulm. Pharmacol. Ther., 2007 - cir.nii.ac.jp
[引用][C] Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
KM Antoniou, A Pataka, D Bouros… - Pulmonary Pharmacology …, 2007 - cir.nii.ac.jp
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …